Evonik Operations Gmbh

Stefan Pelzer

Richard Ducatelle

Filip Van Immerseel

Evy Goossens

Monika Flügel

Michael Schwarm

Bodo Speckmann

Frank Thiemann

Sarah Hark

Walter Pfefferle

Guido Meurer

Alexander Reth

Holger Wallmeier

Ines Ochrombel

Stella Molck

Daniel Petri

Bart Devreese

Florian Böhl

Claudia Borgmeier

Kiran Doranalli

Rose Whelan

Sandra Herbold

Maike Kipker

Griet Debyser

Lynn Vanhaecke

Jessica Kleinbölting

Lieven Van Meulebroek

Günter Raddatz

Emeka-Ignatius Igwe

Thomas Bekel

Michaela Weissmann

Michelle Dargatz

Emeka Ignatius Igwe

Frank Lyko

Andreas Kappel

The invention pertains to an in vitro method for detecting avian intestinal dysbiosis, the method comprising determining the presence and/or level of isoleucyl-arginine (CHON) or isomers thereof in avian sample material wherein the presence and/or an increased level of isoleucyl-arginine (CHON) or isomers thereof in comparison to a non-affected control is indicative for avian intestinal dysbiosis.

In vitro method for detecting avian intestinal dysbiosis

The invention discloses preparations for use in enhancing formation of short-chain fatty acids (SCFAs) in a subject for treating or preventing a disease or disorder comprising at least one omega-3 fatty acid salt having an organic counter ion selected from lysine, arginine, ornithine, choline and mixtures of the same, wherein the omega-3 fatty acid is selected from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and a colon-specific delivery system.

Preparation for use in enhancing formation of short-chain fatty acids (SCFAs)

A synbiotic preparation may include at least one probiotic strain and at least one amino acid or derivative thereof selected from glutamine, glutamic acid or salts thereof, conjugated glutamine, or oligopeptides of 2-10 amino acid units in length, wherein the amino acid units may be natural amino acids, and at least one amino acid unit being a glutamine or glutamic acid unit.

Synbiotic compositions

The present invention pertains to an in vitro method for detecting intestinal barrier failure in an avian population, the method comprising the following steps: a) collecting a pooled fecal sample deriving from an avian population and b) determining the amount of at least one protein marker contained in said sample; wherein the at least one protein marker comprises or consists of an acute phase protein or a functional fragment thereof, and wherein an increased amount of said at least one protein marker contained in said sample versus a reference sample indicates intestinal barrier failure.

In vitro method for detecting intestinal barrier failure in animals

The present invention relates to a method for detectinginduced diseases in animals, the method comprising: a) collecting sample material of a specific animal or of a specific group of animals at consecutive points in time; b) determining the amount of a first marker and a second marker contained in the sample material; and c) determining the ratio of the first marker to the second marker contained in the sample material; wherein the first marker comprises a polynucleotide sequence being specific for thesub-species inducing the targeted disease; and the second marker comprises a polynucleotide being specific for the species; and wherein an increase in the ratio of the first marker to the second marker in the analyzed sample material over time is an indication of the targeted disease.

Method for detectinginduced diseases in animals

The current invention concerns a newstrain with strong inhibition ofand its use as a probiotic.

strain with probiotic activity

Growing community of inventors

Gütersloh, Germany

Stefan Pelzer